NEW YORK (360DX) – For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going where the growth is, and for his firm, China has clearly been the most robust growth opportunity. 

Agena's business today largely comprises the former bioscience unit of Sequenom, now part of Laboratory Corporation of America. While it was still part of Sequenom, the bioscience business, which included the MassArray technology, generated more than half of its revenues in the US.